Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Extension Study of CE1145 (Human Pasteurized C1 Esterase Inhibitor Concentrate) in Subjects With Congenital C1-INH Deficiency and Acute HAE Attacks

NCT00292981 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00292981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00292981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Extension Study of CE1145 (Human Pasteurized C1 Esterase Inhibitor Concentrate) in Subjects With Congenital C1-INH Deficiency and Acute HAE Attacks
Lead sponsor
CSL Behring
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
May 31, 2010
Enrollment
57 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema